Evidence map›Paper›PMID 37520840›Full record

ArticleInfection prevention in practice2023

Multi-drug resistant

Ann Fan Yang, Vivian Huang, Jevon Samaroo-Campbell, Michael Augenbraun

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection prevention in practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Resistance inAntibiotics (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ann Fan YangRutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA.
Vivian HuangMedical School, State University of New York Health Sciences University, New York, NY, USA.
Jevon Samaroo-CampbellDepartment of Internal Medicine, State University of New York Health Sciences University, New York, NY, USA.
Michael AugenbraunDepartment of Infectious Disease, State University of New York Health Sciences University, New York, NY, USA.
State University of New York · USJohnson University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multi-drug resistance in the post COVID-19 world is a growing concern. The objective of this study was to describe temporal trends and explore independent risk factors for the isolation of multi-drug resistant (MDR) Methods: This was a retrospective case-control study of patients with Results: In total, 258 unique isolates were identified. Prolonged hospitalization ( Conclusions: Over a period that coincided with the COVID-19 pandemic, there was an increased proportion of MDR

Indexed as

MDRMulti-drugPseudomonasResistance

Identifiers

PMID37520840
PMCPMC10372386
OpenAlexW4382358221

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.